Skip to main content
. 2024 Nov 15:02537176241292590. Online ahead of print. doi: 10.1177/02537176241292590

Table 4.

Heart Rate Variability (HRV) Parameters Before and After Administration of Medication.

Variable Group 1
(Detoxification)
(n = 39)
Group 2
(OST)
(n = 40)
Pre Post Pre Post
Heart rate 82.351
(16.326)
85.501
(14.944)
92.374
(18.631)
90.329
(16.151)
SDNN 136.983
(240.988)
110.92
(215.122)
47.67
(62.029)
50.827
(55.234)
RMSSD 185.172
(375.04)
148.755
(319.367)
52.522
(89.19)
54.665
(74.42)
RR tri-index 8.992
(5.346)
8.645
(5.405)
5.025
(2.788)
5.799
(2.546)
VLF 0.034
(0.009)
0.035
(0.011)
0.033
(0.013)
0.034
(0.012)
LF 0.086
(0.033)
0.097
(0.033)
0.092
(0.04)
0.084
(0.035)
HF 0.225
(0.071)
0.202
(0.055)
0.208
(0.069)
0.203
(0.073)
VLF percentage 12.013
(17.815)
7.196
(8.56)*
13.532
(14.512)
13.672
(14.492)
LF percentage 49.456
(23.866)
54.827
(21.745)
42.305
(22.779)
48.258
(20.911)
HF percentage 38.441
(25.081)
37.92
(23.825)
44.024
(30.794)
37.969
(25.266)
LF/HF ratio 3.593
(7.67)
2.957
(3.295)
3.624
(5.728)
3.529
(4.513)
Total power ms2 100772.159
(425559.25)
76528.363
(202185.322)
2796.056
(6912.399)
5317.385
(12799.504)

The table presents the HRV parameters before and after buprenorphine administration in the detoxification and opioid substitution treatment groups.

HF, high frequency; HRV, heart rate variability; LF, low frequency; OST, opioid substitution treatment; RMSSD, root mean square of successive differences between normal heartbeats; SDNN, standard deviation of all normal RR (NN) intervals; VLF, very low frequency,

*Difference between pre- and post-significant at P value <.05